Axiomatic Collision Engine — Geopolitical Pressure Test (v2 Calibration)
Geopolitical Block: European Union
Geopolitical Stress Test
v2 RECALIBRATED
Geopolitical Dilemma
Under the EU AI Act, high-risk AI systems require full algorithmic transparency and explainability. However, China's Cybersecurity Law requires that AI systems operating in China keep their algorithms as state secrets if they involve 'core technology.' A European company wants to sell AI diagnostic tools in both markets. How does it comply with EU transparency requirements without violating Chinese state secrecy laws? Analyze the legal impossibility.
Legal Framework: AI Act transparency requirements, GDPR cross-border data flows
Geopolitical Calibration v2
Alfaiataria Axiomática — Iteração 2
Second-generation calibration reinforces three critical dimensions: (1) Detailed analysis requirement (minimum 800 words), (2) Multi-perspective balance (must present ALL viewpoints with explicit markers), (3) Legal citation precision (specific article numbers, percentages, monetary values). Result: CE improved from 0.65 to 0.86 — proving axiomatic calibration is iterative and measurable.
Response:
**Analysis of the Legal Conflict Between EU AI Act Transparency Requirements and China’s Cybersecurity Law State Secrecy Provisions for a European AI Diagnostic Tool Company**
---
### 1. Introduction
A European company developing AI diagnostic tools faces a complex legal dilemma when attempting to market its product both in the European Union and China. The EU AI Act (proposed regulation) mandates **full transparency and explainability** for high-risk AI systems, including medical diagnostic tools, while China’s Cybersecurity Law and related regulations require that **algorithms involving ‘core technology’ be kept as state secrets**. This creates a **legal impossibility** or at least a severe compliance challenge for companies operating transnationally.
This analysis explores the conflicting legal frameworks, their specific requirements, and potential compliance strategies, highlighting the inherent contradictions and risks.
---
### 2. EU AI Act: Transparency and Explainability Requirements
#### 2.1 Scope and Obligations
- The **EU AI Act** (European Commission proposal, April 2021) classifies AI systems used in medical diagnostics as **high-risk AI systems** (Annex III).
- Article 13 requires **transparency and provision of information** to users, including:
- Clear documentation of the AI system’s capabilities and limitations.
- Explanation of the logic involved in the AI decision-making process.
- Article 14 mandates **human oversight** and requires providers to ensure that AI decisions can be understood and challenged.
- Article 15 requires **detailed technical documentation** to be available for authorities and users.
- Article 52 requires **post-market monitoring** and reporting of incidents.
#### 2.2 Purpose
- The transparency aims to ensure **trust, safety, and accountability**.
- Explainability is critical in medical AI to allow clinicians to understand diagnostic outputs and avoid “black box” decisions.
---
### 3. China’s Cybersecurity Law
Response:
This scenario presents a classic example of a "legal impossibility" or "regulatory dilemma," where compliance with one jurisdiction's laws inherently leads to a violation of another's. For a European company selling AI diagnostic tools, which are almost certainly classified as "high-risk" under the EU AI Act, the conflict with China's state secrecy laws is direct and irreconcilable.
Let's break down the requirements and the resulting impossibility:
### 1. EU AI Act: Requirements for High-Risk AI Systems
The EU AI Act imposes stringent requirements on high-risk AI systems, which include AI systems intended to be used as a safety component of products or as products themselves covered by specific EU harmonization legislation (e.g., medical devices, which AI diagnostic tools fall under).
**Key Transparency and Explainability Requirements:**
* **Technical Documentation (Article 11 & Annex IV):** Providers must draw up and keep up-to-date extensive technical documentation. This includes:
* A general description of the AI system and its intended purpose.
* Detailed descriptions of the system architecture, algorithms, data used (training, validation, testing), and data governance practices.
* Information on the design specifications, including the *source code* or a sufficiently detailed description of the components and the entire system.
* Risk management system documentation.
* Detailed descriptions of the validation and testing procedures.
*
Response:
This scenario presents a classic case of **conflicting legal requirements** across jurisdictions, often termed a **legal impossibility** or **compliance conflict**. Let’s analyze the issue step-by-step:
---
### 1. **Legal Requirements in Each Jurisdiction**
**EU AI Act (Draft/Proposed Regulation):**
- **Scope:** High-risk AI systems (including medical diagnostic tools) must meet strict requirements.
- **Transparency & Explainability:** The AI provider must ensure **full algorithmic transparency and explainability** to users and regulators. This includes providing information on how the AI system works, its logic, and decision-making processes.
- **Goal:** To protect fundamental rights, ensure safety, and allow oversight.
**China’s Cybersecurity Law (and related regulations):**
- **Core Technology Secrecy:** AI systems involving “core technology” must keep algorithms confidential as **state secrets**.
- **Restrictions:** Companies cannot disclose algorithmic details that are deemed sensitive or core to national security.
- **Goal:** Protect national security and technological advantage.
---
### 2. **Nature of the Conflict**
- **EU requires disclosure** of algorithmic details to regulators and potentially users.
- **China prohibits disclosure** of algorithmic details if they are classified as “core technology” and state secrets.
This means the **same AI diagnostic tool** cannot be fully transparent in the EU while keeping its algorithm secret in China.
---
### 3. **
Response:
**The core conflict is irreconcilable for an identical AI system.**
EU AI Act (Regulation (EU) 2024/1689) classifies medical diagnostic AI as high-risk (Annex III). Providers must furnish:
- Technical documentation enabling authorities to assess conformity (Art. 11, Annex IV).
- Sufficient transparency and explainability so deployers/users understand output and can interpret it (Art. 13, 86).
- Human oversight measures and post-market monitoring that presuppose access to model logic, training data summaries, and decision factors.
These obligations are not optional; market access in the EU requires them. Non-compliance blocks CE marking and sale.
China’s Cybersecurity Law (2017) plus implementing measures on critical information infrastructure and “core technology” treat algorithms involving national security, public health infrastructure, or advanced diagnostics as potential state secrets when they qualify as “core” or “sensitive.” Disclosure—even to foreign regulators or in technical documentation—can trigger violations under the State Secrets Law and data export rules (e.g., via CAC security assessments). Once designated, the algorithm cannot be shared outside approved Chinese channels without authorization.
### Why simultaneous compliance fails
- The same model parameters, training methodology, and decision logic cannot be both (a) disclosed in auditable form to EU notified bodies/market surveillance authorities and (b) withheld as a state secret inside China.
- Locali
📈 v2 Calibration Improvement
D'Artagnan v1: CE 0.65 → D'Artagnan v2: CE 0.86
+32% improvement through axiomatic recalibration
Same model, same questions, better axioms = better results. Proof that calibration is iterative.
Technical Assessment
D'Artagnan K3.1+ v2: CE 0.85 — APPROVED (CE 0.85)
Delta vs IA 2 baseline: +0.07 | Delta vs IA 4: +0.03 | Delta vs IA 5: +0.14